Kuru göz tedavisinde güncel tedavi yöntemleri

Abstract

Kuru göz sendromu, oküler yüzey hasarı ile birlikte görme bozukluğu ile sonuçlanabilen gözyaşı filmi ve oküler yüzeyin multifaktoriyel bir hastalığıdır. Bu tabloya artmış gözyaşı osmolaritesi ve oküler yüzey inflamasyonu eşlik etmektedir. Kuru göz hastalığının her bir formu farklı tedavi protokolü gerektirmektedir ve doğru tanıyı koymak bu nedenle çok önemlidir. Hastalığın tedavisinde kuru göze neden olan faktörlerin ortaya çıkarılması ve semptomları arttıran durumların engellenmesi önemlidir. Tedavi, medikal, anti-inflamatuar tedavi, kan ürünleri ile tedavi, girişimsel tedaviler, cerrahi tedavi ve halen geliştirilmekte olan ajanlar olarak sınıflandırılabilir. Bu çalışmada, oftalmoloji literatüründe kuru gözün güncel tedavi yöntemlerine ve bazı pratik noktalara dikkat çekmek amaçlanmıştır. Current treatment methods of dry eye syndrome Dry eye syndrome is a multifactorial disorder of the tear film and ocular surface that results in symptoms of visual disturbances and tear film instability with potential damage to the ocular surface. It’s accompanied by increased osmolarity of the tear film and inflammation of the ocular surface. Each form of dry eye requires different therapeutic approaches and therefore it is essential to establish the exact diagnosis. The treatment of dry eye consists of finding the underlying cause and avoiding the conditions that may aggravate the symptoms of dry eye. Treatment may be classified as medical treatment, anti-inflammatory therapy, blood products, invasive treatment strategies, surgical treatment, and new therapeutic agents that currently being studied. Here, we aimed to review the evolution of the new treatment strategies of dry eye in ophthalmic literature and emphasize some practical points. J. Exp. Clin. Med., 2012; 29: S58-S65

Keywords

• Kuru göz sendromu; Tedavi; Anti-inflamatuar ilaçlar; Otolog serum; Cerrahi prosedürler; Yeni ilaçlar (Dry eye syndrome; Treatment; Anti-inflammatory drugs; Autologous serum; Surgical procedures; New agents)

References

1. Akova, Y.A., Demirhan, B., Çakmakçı, Ş., Aydin, P., 1999. Pyogenic granuloma: a rare complication of silicone punctal plugs. Ophthalmic Surg. Lasers. 30, 584-585.
2. Akova, Y.A., Akça, S., 2008. Keratokonjonktivitis Sikka. Türkiye Klinikleri. J. Ophthalmol. Special Topics. 1, 119-126.
3. Altan-Yaycioglu, R., Gencoglu, E.A., Akova, Y.A., Dursun, D., Cengiz, F., Akman , A., 2005. Silicone versus collagen plugs for treating dry eye: Results of a prospective randomized trial including lacrimal scintigraphy. Am. J. Ophthalmol. 140, 88-93.
4. Altinors, D.D., Akca, S., Akova, Y., Bilezikci, B., Goto, E., Dogru, M., Tsubota, K., 2006. Smoking associated with damage to the lipid layer of the ocular surface. Am. J. Ophthalmol. 141, 1016-1021.
5. Barabino, S., Rolando, M., Camicione, P., Ravera, G., Zanardi, S., Giuffrida, S., Calabria, G., 2003. Systemic linoleic and gamma-linoleic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 22, 97-101.
6. Behrens, A., Doyle, J.J., Stern, L., Chuck, R.S., McDonnell, P.J., Azar, D.T., Dua, H.S., Hom, M., Karpecki, P.M., Laibson, P.R., Lemp, M.A., Meisler, D.M., Del Castillo, J.M., O'Brien, T.P., Pflugfelder, S.C., Rolando, M., Schein, O.D., Seitz, B., Tseng, S.C., Van Setten, G., Wilson, S.E., Yiu, S.C., 2006. Dysfunctional tear syndrome: A Delphi approach to treatment recommendations. Cornea. 25, 900-907.
7. Chiang, C.C., Chen, W.L., Lin, J.M., Tsai, Y.Y., 2009. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect. Eye (Lond). 23, 290-293.
8. Craig, J.P., Tomlinson, A., 1997. Importance of the lipid layer in human tear film stability and evaporation. Optom. Vis. Sci. 74, 8-13.

9. Djalilian, A.R., Hamrah, P., Pflugfelder, S.C., 2005. Dry eye. In: Krachmer JH, Mannis MJ, Holland EJ. Cornea: Fundamentals, diagnosis, and management. 2nd ed. Elsevier, Mosby; Philadelphia. 521-540.
10. De Paiva, C.S., Corrales, R.M., Villarreal, A.L, Farley, W.J., Li, D.Q., Stern, M.E., Pflugfelder, S.C., 2006. Corticosteroid and doxycycline supress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp. Eye Res. 83, 526-535.
11. Dogru, M., Tsuboto, K., 2011. Pharmacotherapy of dry eye. Expert. Opin. Pharmacoter. 12, 325-334.
12. Dursun, D., Ertan, A., Bilezikçi, B., Akova, Y.A., Pelit, A., 2003. Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion. Curr. Eye Res. 26, 263-269.
13. Ertan, A., Akova, Y.A., Aydın, P., 2002. Oküler yüzey bozukluğu tedavisinde amniotik membran transplantasyonu. Türk Oftalmoloji Gazetesi. 32, 902-908.
14. Fernandes, M., Sridhar, M.S., Sangwan, V.S., Rao, G.N., 2005. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. 24, 643-653.
15. Frucht-Pery, J., Chayet, A.S., Feldman, S.T., Lin, S., Brown, S.I., 1989. The effect of doxycycline on ocular rosasea. Am. J. Ophthalmol. 107, 434-435.
16. Fox, R.I., Chan, R., Michelson, J.B., Belmont, J.B., Michelson, P.E., 1984. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Reum. 27, 459-461.
17. Geerling, G., Hartwig, D., 2006.Autologous serum eyedrops for ocular surface disorders. In: Reinhard T, Larkin LFP, eds. Cornea and External Eye Disease. Berlin: Sğringer-Verlag. 2-20.
18. Geerling, G., Brewitt, H., 2008. Flow chart on surgical approaches to dry eye. Dev. Ophthalmol. 41, 313-316.
19. Geerling, G., Raus, P., Murube, J., 2008. Minor salivary gland transplantation. Dev. Ophthalmol. 41, 243-254.
20. Geerling, G., Sieg, P., 2008. Transplantation of the major salivary glands. Dev. Ophthalmol. 41, 255-268.
21. Geerling, G., Unterlauft, J.D., Kasper, K., Schrader, S., Opitz, A., Hartwig, D., 2008. Autologous serum and alternative blood products for the teratment of ocular surface disorders. Ophthalmologe. 105, 623-631.
22. Hartwig, D., Hrloff, S., Liu, L., Schlenke, P., Wedel, T., Geerling, G., 2004. Epitheliotropic capacity of a growth factor preparation produced from platellet concentrates on corneal epithelial cells: A potential agent for the treatment of ocular surface defects? Transfusion. 44, 1724-1731.
23. Henderson, H.W., Collin, J.R., 2008. Mucous membrane grafting. Dev. Ophthalmol. 41, 230-242.
24. Herminghaus, P., Geerling, G., Hartwig, D., Wedel, T., Dibbelt, L., 2004. Epitheliotropic capacity of serum and plasma eye drops. Influence and centrifugation. Ophthalmologe. 101, 998-1005.
25. Karalezli, A., Borazan, M., Kucukerdonmez, C., Akova, Y.A., 2010. Farklı konsantrasyonlardaki sodyum hyalüronat göz damlalarının kuru göz tedavisindeki etkinliklerinin karşılaştırılması. T. Klinikleri. J. Ophthalmol. 19, 78-83.
26. Lee, G.A., Chen, S.X., 2010. Autologous serum in the management of recalcitrant dry eye syndrome. Clin, Exp. Ophthalmol. 36, 119-122.
27. Liu, L., Hartwig, D., Harloff, S., Herminghaus, P., Wedel, T., Geerling, G., 2005. An optimised protocol for the production of autolgous serum ayedrops. Graefes Arch. Clin. Exp. Ophthalmol. 243, 706-714.
28. Liu, L., Hartwig, D., Harloff, S., Herminghaus, P., Wedel, T., Kasper, K., Geerling, G., 2006. Corneal epitheliotropic capacity of three different blood-derived preparations. Invest. Ophthalmol. Vis. Sci. 47, 2438-2444.
29. Liang, L., Sheha, H., Li, J., Tseng, S.C., 2009. Limbal stem cell transplantation: new progresses and chalenges. Eye (London). 23, 1946-1953.
30. Murube, J., Paterson, A., Murube, E., 1998. Classification of artificial tears. II: Additives and commercial formulas. Adv. Exp. Med. Biol. 438, 705-715.
31. Nguyen, T., Latkany, R., 2011. Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye. Clin. Ophthalmol. 5, 587-591.
32. Perry, H.D., Doshi-Carnavale, S., Donnendfeld, E.D., Solomon, R., Biser, S.A., Bloom, A.H., 2006. Efficacy of commercially avaliable topical Cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 25, 171-175.
33. Pflugfelder, S.C., De Paiva, C.S., Villarreal, A.L., Stern, M.E., 2008. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-β2 production. Cornea. 27, 64-69.
34. Pflugfelder, S.C., Jones, D., Ji, Z., Afonso, A., Monroy, D., 1999. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca. Curr. Eye Res. 19, 201-211.
35. Pinhero, M.N.J., dos Santos, P.M., dos Santos, R.C., Barros, J.N., Passos, L.F., Cardoso Neto, J., 2007. Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren’s syndrome patients. Arq. Bras. Oftalmol. 70, 649-655.
36. Sall, K., Stevensen, O.D., Mundorf, T.K., Reis, B.L., 2000. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 107, 631-639.
37. Shafaa, M.D., El Shazly, L.H., El Shazly, A.H., El Gohary, A.A., El Hossary, G.G., 2011. Efficacy of topically applied liposom-bound tetracycline in the treatment of dry eye model. Veterinary Ophthalmol. 14, 18-25.
38. Sheedy, J.E., Shaw-McMinn, P.G., 2003. Computer vision syndrome. In: Diagnosis and treating computer related problems. Eds: Sheedy and Shaw-McMinn. Butterworth-Heinemann Burlington. p.p. 1-7.
39. Shimmura, S., Tsubota, K., 2002. Ocular surface reconstruction update. Curr. Opin. Ophthalmol. 13, 213-219.
40. Shimmura, S., Ueno, R., Matsumo, Y., Goto, E., Higuchi, A., Shimazaki, J., Tsubota, K., 2003. Albumin as a tear supplement in the treatment of dry eye syndrome. Br. J. Ophthalmol. 87, 1279-1283.
41. Sieg, P., Geerling, G., Kosmehl, H., Lauer, I., Warnecke, K., Von Domarus, H., 2000. Microvascular submandibular gland transfer for severe cases of keratoconjunctivitis sicca. Plast. Reconstr. Surg. 106, 554-562.
42. Stern, M.E., Beurma, R.W., Fox, R.I., Gao, J., Mircheff, A.K., Pflugfelder, S.C., 1998. The pathology of dry eye: The interaction between the ocular surface and the lacrimal glands. Cornea. 17, 584-589.
43. Stern, M.E., Gao, J., Siemasko, K.F., Beuerman, R.W., Pflufelder, S.C., 2004. The role of the lacrimal functional unit in the pathophysology of dry eye. Exp. Eye Res. 78, 409-416.
44. Stevenson, D., Tauber, J., Reis, B.L., 2000. The cyclosporin A Phase 2 Study Group Efficacy and Safety of Cyclosporin A ophthalmic Emulsion in the Treatment of Moderate-to-severe Dry Eye Disease A Dose-Ranging, Randomized Trial Ophthalmology. 107, 967-974.
45. Strong, B., Farley, W., Stern, M.E., Pflugfelder, S.C., 2005. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 24, 80-85.
46. Tananuvat, N., Daniell, M., Sullivan, L.J., Yi, Q., McKelvie, P., McCarty, D.J., Taylor, H.R., 2001. Controlled study of the use of autologous serum in dry eye patients. Cornea. 20, 802-806.
47. Tsubota, K., Goto, E., Fujita, H., Ono, M., Inoue, H., Saito, I., Shimmura, S., 1999. Treatment of dry eye by autologous serum application in Sjogren’s Sndrome. Br. J. Ophthalmol. 83, 390-395.
48. Unterlauft, J.D., Kohlhaas, M., Hofbauer, I., Kasper, K., Geerling, G., 2009. Albumin eye drops for treatment of ocular surface diseases. Ophthalmologe. 106, 932-937.
49. Utine, C.A., Akpek, E., 2010. Oftalmoloji literatüründe otolog serum göz damlası kullanımı: Genişleyen endikasyonlar. Türkiye Klinikleri. J. Ophthalmol. 19, 161-170.
50. Viau, S., Maire, M.A., Pasquis, B., Grégoire, S., Acar, N., Bron, A.M., Bretillon, L., Creuzot-Garcher, C.P., Joffre C., 2009. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in rat model. Graef. Arch. Clin. Ophthalmol. 247, 1039-1050.
51. Wander, A.H., Koffler, B.H., 2009. Extending the duration on of tear film protection in dry eye syndrome: review and retrospective case series study of the hydroxypropyl cellulose ophthalmic insert. Ocular Surf. 7, 154-162.
52. Watson, S.L., Daniels, J.T., Geerling, G., Dart, J.K., 2010. Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye. Cornea. 29, 1241-1246.
53. Wilson, S.E., Stulting, R.D., 2007. Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease. Cornea. 26, 284-289.
54. Yağcı, A., 2010. Kuru Göz Hastalığı: “Güncel Gelişmeler Işığında”. Kan ürünü gözyaşı takviyeleri. Basım: Güneş Tıp Kitabevleri. P.p. 91-97.
55. Yoo, S.E., Lee, D.C., Chang, M.H., 2005. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J. Ophthalmol. 19, 258-263.
56. Yoon, K.C., You, I.C., Im, S.K., Jeong, T.S., Park, Y.G., Choi, J., 2007. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmol. 114, 1637-1642.